In contrast to myeloid leukemia, this study showed that CD33 expression in all patients with APL was bright, CD13 expression was dim to bright, cMPO expression was dim to moderate, and CD117 expression was generally dim. This evidence concerns the gene KIT and acute promyelocytic leukemia.